CCL2 and Obesity: However, we could not document a higher inflammatory burden as measured by YKL-40 and MCP-1 levels among type 2 diabetes patients compared to otherwise healthy obese subjects, perhaps explained by the severe obesity in both groups, which may have been the main contributor to the inflammation compared with type 2 diabetes per se.